<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08052742101615</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV025010</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:39.916Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101608</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP010005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:38.709Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101592</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP010005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:32.713Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101585</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP014005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:31.511Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101578</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP014005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:30.305Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101561</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP015005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:29.112Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101554</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP015005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:23.104Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101547</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP025005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:21.900Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101530</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSP025005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:20.703Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101523</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV010005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:19.499Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101516</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV010005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:13.497Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101509</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV014005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:12.301Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101493</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV014005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:11.097Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101486</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV015005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:09.910Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101479</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV015005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:03.887Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101462</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>YaluVISTA®</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV025005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:02.695Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101455</udiDi>
    <basicUdiDi>805274210OculadZJ</basicUdiDi>
    <tradeName>Oculade</tradeName>
    <deviceName>Oculade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIOSV025005</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:01.492Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101448</udiDi>
    <basicUdiDi>805274210ArticuZK</basicUdiDi>
    <tradeName>YaluMOVE®</tradeName>
    <deviceName>Articulade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIISP010050</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:51:00.283Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101431</udiDi>
    <basicUdiDi>805274210ArticuZK</basicUdiDi>
    <tradeName>Articulade</tradeName>
    <deviceName>Articulade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIISP010050</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:50:54.287Z</lastUpdated>
  </row>
  <row>
    <udiDi>08052742101424</udiDi>
    <basicUdiDi>805274210ArticuZK</basicUdiDi>
    <tradeName>YaluMOVE®</tradeName>
    <deviceName>Articulade</deviceName>
    <manufacturerName>S.A.L.F. S.p.A. Laboratorio Farmacologico</manufacturerName>
    <manufacturerSrn>IT-MF-000010720</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SIISP010040</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-06-30T11:50:53.084Z</lastUpdated>
  </row>
</eudamedExport>